ZA894835B - Antiviral combinations and compounds therefor - Google Patents

Antiviral combinations and compounds therefor

Info

Publication number
ZA894835B
ZA894835B ZA894835A ZA894835A ZA894835B ZA 894835 B ZA894835 B ZA 894835B ZA 894835 A ZA894835 A ZA 894835A ZA 894835 A ZA894835 A ZA 894835A ZA 894835 B ZA894835 B ZA 894835B
Authority
ZA
South Africa
Prior art keywords
compounds therefor
antiviral combinations
ribonucleotide reductase
antiviral
combinations
Prior art date
Application number
ZA894835A
Other languages
English (en)
Inventor
Todd Andrew Blumenkopf
Andrew Blumenkopf Todd
Thomas Spector
Spector Thomas
Devron Randolph Averett
Randolph Averett Devron
Robert William Morrison
William Morrison Robert
Eric Cleveland Bigham
Cleveland Bigham Eric
Virgil Lee Styles
Lee Styles Virgil
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZA894835B publication Critical patent/ZA894835B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA894835A 1988-06-27 1989-06-26 Antiviral combinations and compounds therefor ZA894835B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888815241A GB8815241D0 (en) 1988-06-27 1988-06-27 Antiviral combinations & compounds therefor

Publications (1)

Publication Number Publication Date
ZA894835B true ZA894835B (en) 1991-02-27

Family

ID=10639423

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA894835A ZA894835B (en) 1988-06-27 1989-06-26 Antiviral combinations and compounds therefor

Country Status (19)

Country Link
US (3) US5021437A (es)
EP (1) EP0349243B1 (es)
JP (1) JPH0245423A (es)
KR (1) KR910000149A (es)
AT (1) ATE74276T1 (es)
AU (1) AU626304B2 (es)
DE (1) DE68901111D1 (es)
DK (1) DK315889A (es)
ES (1) ES2031357T3 (es)
FI (1) FI893112A (es)
GB (1) GB8815241D0 (es)
GR (1) GR3005067T3 (es)
HU (1) HU206264B (es)
IE (1) IE64496B1 (es)
IL (1) IL90750A0 (es)
MY (1) MY106304A (es)
NZ (1) NZ229711A (es)
PT (1) PT90972B (es)
ZA (1) ZA894835B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164395A (en) * 1988-06-27 1992-11-17 Burroughs Wellcome Co. Antiviral acetyl pyridine derivative or said acetyl pyridine derivative in combination with acyclovir
GB8815241D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Antiviral combinations & compounds therefor
US5674849A (en) * 1990-10-24 1997-10-07 Allelix Biopharmaceuticals Inc. Anti-viral compositions
CA2033447C (en) * 1990-12-31 1999-08-31 Robert Deziel Synergistic combination for treating herpes infections
CA2033448C (en) * 1990-12-31 1996-11-26 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes compositions and method of use
US5879700A (en) * 1991-10-15 1999-03-09 Hostetler; Karl Y. Nucleoside analogue phosphates for topical use
US5580571A (en) * 1991-10-15 1996-12-03 Hostetler; Karl Y. Nucleoside analogues
WO1994026273A1 (en) * 1993-05-12 1994-11-24 Hostetler Karl Y Acyclovir derivatives for topical use
US6015573A (en) * 1993-05-12 2000-01-18 Hostetler; Karl Y. Nucleoside phosphate therapy for viral infection
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
GB9315755D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized formulation
WO1996001638A1 (en) * 1994-07-11 1996-01-25 Hoechst Marion Roussel, Inc. Method of treating a neoplastic disease state by conjunctive therapy with 2'-fluoromethylidene derivatives and radiation or chemotherapy
US5693791A (en) * 1995-04-11 1997-12-02 Truett; William L. Antibiotics and process for preparation
CA2224008C (en) * 1995-06-07 2009-08-18 Trimeris, Inc. The treatment of hiv and other viral infections using combinatorial therapy
US20030212051A1 (en) * 2001-04-06 2003-11-13 Polli James E Bile acid containing prodrugs with enhanced bioavailabilty
US20080132527A1 (en) 2004-05-19 2008-06-05 Emisphere Technologies, Inc. Compositions For Delivering Acyclovir
JP4972062B2 (ja) * 2008-03-17 2012-07-11 メディヴィル・アクチエボラーグ 抗ウイルス製剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
US4777166A (en) * 1982-03-30 1988-10-11 The United States Of America As Represented By The Secretary Of The Army 2-acetylpyridine thiosemicarbazone compositions as anitviral agents
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
GB8320308D0 (en) * 1983-07-28 1983-09-01 Wellcome Found Antiviral combinations
US4606917A (en) * 1984-10-03 1986-08-19 Syntex (U.S.A) Inc. Synergistic antiviral composition
US4751221A (en) * 1985-10-18 1988-06-14 Sloan-Kettering Institute For Cancer Research 2-fluoro-arabinofuranosyl purine nucleosides
US4829055A (en) * 1987-01-23 1989-05-09 Naficy Sadeque S Method of treatment for herpes infections of external tissues
GB8815241D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Antiviral combinations & compounds therefor
GB8823320D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds
GB8823319D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds

Also Published As

Publication number Publication date
HU206264B (en) 1992-10-28
AU3702689A (en) 1990-02-01
US5021437A (en) 1991-06-04
MY106304A (en) 1995-04-29
EP0349243B1 (en) 1992-04-01
IL90750A0 (en) 1990-01-18
NZ229711A (en) 1992-08-26
ES2031357T3 (es) 1992-12-01
DK315889D0 (da) 1989-06-26
DK315889A (da) 1989-12-28
PT90972B (pt) 1995-01-31
HUT52379A (en) 1990-07-28
PT90972A (pt) 1989-12-29
AU626304B2 (en) 1992-07-30
US5175165A (en) 1992-12-29
JPH0245423A (ja) 1990-02-15
FI893112A (fi) 1989-12-28
US5393883A (en) 1995-02-28
IE64496B1 (en) 1995-08-09
IE892060L (en) 1989-12-27
ATE74276T1 (de) 1992-04-15
FI893112A0 (fi) 1989-06-26
KR910000149A (ko) 1991-01-29
GR3005067T3 (es) 1993-05-24
EP0349243A2 (en) 1990-01-03
DE68901111D1 (de) 1992-05-07
GB8815241D0 (en) 1988-08-03
EP0349243A3 (en) 1990-07-11

Similar Documents

Publication Publication Date Title
EP0349243A3 (en) Antiviral combinations and compounds therefor
EP0677048A1 (en) CYCLIC SULPHONES AS INHIBITORS RETROVIRAL PROTEASES.
EP0810209A3 (en) Alpha - and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
DE69811062D1 (de) Polyaromatische antivirale zusammensetzungen
HK1002257A1 (en) Cyclic ureas and analogues useful as retroviral protease inhibitors
WO1993012781A3 (en) Creatine analogs having antiviral activity
GR3026222T3 (en) Novel mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
ES2160046A1 (es) Derivados pentapeptidicos.
AU9125191A (en) Retroviral protease inhibitors
CA2140928A1 (en) Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
CA2129132A1 (en) Antiviral agent
AU2489197A (en) Carbocyclic intermediates and process of manufacture thereof
HUT71105A (en) Mercaptoacylamino-substituted benzazepines condensed with heterocycles, process for preparing them and pharmaceutical compositions of enkephalinase and ace inhibitor activity containing said compounds
AU3595589A (en) Hirudin derivatives with delayed action
ZA94748B (en) Cytotoxic and antiviral compound.